S2 E11 - Headaches, AZ and Thrombosis; Green Light for Inhaled Steroids in GP; Risk of death on discharge post-COVID | NB Medical
 

S2 E11 - Headaches, AZ and Thrombosis; Green Light for Inhaled Steroids in GP; Risk of death on discharge post-COVID

NO
PHARMACEUTICAL INFLUENCE
NO PHARMACEUTICAL INFLUENCE
16th April 2021

If you are having difficulties listening to this Podcast, try to play this episode in Spotify

The big news this week has been the risk of cerebral venous sinus thrombosis post-AZ vaccine and it's been giving us all a headache, but this has overshadowed further new data confirming benefit of inhaled corticosteroids for acute mild covid and guidance that we can offer this to older patients on a case-by-case basis.

In the latest Hot Topics podcast Neal Tucker discusses the facts, figures, management and ethics of post-AZ vaccine thrombosis, reviews the Principle trial showing we now have a viable treatment for mild covid; and data on the rate of multi-organ dysfunction and death at 4 months post-hospital discharge for covid.

References

MHRA data on AZ vaccine and thrombosis risk

CDC Data on Johnson&Johnson vaccine and thrombosis risk

CDC Data on Transmission Reduction

STOIC trial Lancet Resp

Principle trial

NHS recommendations from the Principle trial data

BMJ post-covid syndrome data

UnHerd Did I Give My Patients COVID?